ADVERTISEMENT
Current and Future Landscape of AD Treatment Part 1
In this exclusive interview as part of the National Eczema Association’s Atopic Dermatitis (AD) Expert Series, Dr Tina Bhutani discusses the current therapeutic options and what’s down the pipeline for atopic dermatitis treatment. Additional Resources: nationaleczema.org/hcp-resource-hub and https://nationaleczema.org/research/eczema-treatment-research
Tina Bhutani, MD, MAS, is an associate professor of the department of dermatology at University of California in San Francisco, CA. She is also a co-director of the Psoriasis and Skin Treatment Center, and a director of the Dermatology Clinical Research Unit in San Francisco.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
Advertisement
Advertisement
Advertisement
Advertisement
Popular Articles
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement